DUPILUMAB

Drug action

Dupilumab is a recombinant human monoclonal antibody that inhibits interleukin-4 and interleukin-13 signaling.

Indications and dose

Moderate-to-severe atopic eczema (initiated by a ...

This item requires a subscription.
For full access to this content, log in to an existing user account or purchase an individual subscription.
×
Sign in or create an account
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. Sign in or purchase a subscription to access this content. ×